Takeda Diabetes - 搜索图片

1038 x 469 · png
seekingalpha.com
Takeda Pharmaceutical Co: A Bright Decade Ahead (NYSE:TAK) | Seeking Alpha
1242 x 810 · jpeg
wsj.com
Takeda, Lilly Ordered to Pay $9 Billion in Diabetes-Drug Case - WSJ
1280 x 720 · jpeg
pharmaceutical-technology.com
Takeda to sell diabetes products portfolio to Teijin Pharma for $1.25bn

1280 x 902 · jpeg
nippon.com
Japan’s Takeda sells four diabetes products to Teijin Pharma for $1.25 ...
2048 x 1152 · jpeg
endpts.com
Takeda’s rare disease drug’s manufacturing and supply woes continue as ...
3200 x 1680 · jpeg
usatoday.com
Japan's Takeda agrees to pay $2.4B ln in diabetes drug suit
461 x 599 · jpeg
clinicaltrialsarena.com
Takeda TAK-875 drug shows effic…

2500 x 1394 · jpeg
ibtimes.com
Japan's Takeda Agrees To $2.4B Settlement In Diabetes Drug Actos ...
1440 x 962 · jpeg
The Boston Globe
Japanese drug giant Takeda will move its US headquarters to the …
2560 x 1707 · jpeg
endpts.com
Takeda ending discovery, preclinical work in AAV gene ther…
974 x 543 · jpeg
dealstreetasia.com
Japan's Takeda to sell some Asia-focused drugs to Celltrion for $278m

2272 x 1704 · jpeg
fiercebiotech.com
NuBiyota pact continues Takeda’s GI, microbiome deal …
1920 x 1280 · jpeg
medium.com
Takeda – Medium
1200 x 627 · jpeg
businesswire.com
Takeda Announces Candidates for Board of Directors at Upcoming ...
1916 x 1275 · jpeg
asia.nikkei.com
Takeda transferring some drug development to joint venture - Nikk…

1200 x 900 · jpeg
kozonoayumi.hatenablog.com
507食目「Takeda Diabetes Academy」糖尿病全国Web講演会で講演させ …
1024 x 576 · jpeg
news.cgtn.com
Takeda banks on innovative product lineup for success in China - CGTN
1500 x 900 · jpeg
medicaldialogues.in
Takeda declares positive results in Phase 2b Study of TAK-279 in peopl…
2000 x 1333 · jpeg
japantimes.co.jp
Takeda dengue vaccine meets main goal of trial; detailed result…

1600 x 900 · jpeg
statnews.com
Takeda | STAT
700 x 432 · jpeg
minitab.com
Takeda Boosts Drug Production with the Help of Machine Learning Mod…
960 x 682 · jpeg
reuters.com
Takeda Pharma gets US FDA approval for rare blood disord…
1400 x 791 · jpeg
asia.nikkei.com
Takeda looks to supplements to pep up China sales - Nikkei Asia

1200 x 900 · jpeg
kozonoayumi.hatenablog.com
507食目「Takeda Diabetes Academy」糖尿病全国Web講演 …
2000 x 1333 · jpeg
japantimes.co.jp
Japan drugmaker Takeda mulls sale of $3 billion in emerging-market ...
1200 x 900 · jpeg
kozonoayumi.hatenablog.com
507食目「Takeda Diabetes Academy」糖尿病全国Web講演 …
600 x 452 · jpeg
kalkinemedia.com
Takeda’s ADZYNMA (ADAMTS13, recombinant-krhn) Approved by U.S…

3454 x 2951 · jpeg
asia.nikkei.com
Takeda to tout new drugs in emerging markets - Nikk…
600 x 600 · jpeg
foursquare.com
PT. Takeda Indonesia, Factory - Factory in …
474 x 489 · jpeg
clinicaltrials.takeda.com
Takeda Clinical Trials
770 x 510 · jpeg
yicaiglobal.com
[Exclusive] Takeda Pharma Envisions China to Overtake Japa…
960 x 540 · jpeg
pharmaphorum.com
Takeda bags FDA okay for Fruzaqla in colorectal cancer | pharmaphorum

1280 x 720 · jpeg
medicircle.in
Takeda completes sale of select OTC and non-core assets to Celltrion in ...
1400 x 787 · jpeg
asia.nikkei.com
Takeda works on drug to treat COVID complications - Nikkei Asia
1600 x 900 · jpeg
asia.nikkei.com
Takeda to give foreign directors two-thirds majority on board - Nikkei Asia

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果